Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Treasury Shares (2017 - 2025)

Haemonetics has reported Treasury Shares over the past 16 years, most recently at $332292.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $332292.0 for Q4 2025, up 58.62% from a year ago — trailing twelve months through Dec 2025 was $332292.0 (up 58.62% YoY), and the annual figure for FY2025 was $303003.0, down 18.06%.
  • Treasury Shares for Q4 2025 was $332292.0 at Haemonetics, down from $1.4 million in the prior quarter.
  • Over the last five years, Treasury Shares for HAE hit a ceiling of $1.4 million in Q3 2025 and a floor of $209494.0 in Q4 2024.
  • Median Treasury Shares over the past 5 years was $348089.0 (2025), compared with a mean of $527800.9.
  • Biggest five-year swings in Treasury Shares: crashed 83.25% in 2021 and later soared 252.36% in 2023.
  • Haemonetics' Treasury Shares stood at $248463.0 in 2021, then decreased by 15.08% to $211000.0 in 2022, then surged by 372.51% to $997000.0 in 2023, then plummeted by 78.99% to $209494.0 in 2024, then soared by 58.62% to $332292.0 in 2025.
  • The last three reported values for Treasury Shares were $332292.0 (Q4 2025), $1.4 million (Q3 2025), and $363886.0 (Q2 2025) per Business Quant data.